PRODUCTS

ColoDefense® Multiplex Stool DNA Methylation Test Kit for Colorectal Cancer

This kit detects the presence of multiple DNA methylation biomarkers in a patient’s stool by highly sensitive fluorescent quantitative PCR technique to determine the patient’s risk for colorectal tumor.

  • Product Description

    Product features

    1. It can be used for early screening of colorectal cancer, auxiliary diagnosis, and prognosis of postoperative recurrence.
    2. It achieves high sensitivity and specificity through the combination of bioinformatics-based system thermodynamics guided design and simultaneous detection of multiple methylation biomarkers.
    3. It features non-invasive detection, in-home sampling, and high public acceptance compared with colonoscopy;
    4. It is easy and fast to operate, with low cost;
    5. It can detect advanced adenomas and early CRCs better than other commercially available stool based screening products.
    6. All raw materials are home-made.

     

    Technical performance indicators

    Test results of more than 1,000 clinical samples show the following:

    1. The sensitivities of this kit for the detection of stage I-II colorectal cancer, stage I-IV colorectal cancer and advanced adenomas are 93%, 92% and 67%, respectively.
    2. And its specificity stands at 92%.

     

     

    Note: This kit is for research use only, not for clinical diagnosis.